AccuPulse develops a pulsed electric field ablation (PFA) platform that uses high‑voltage, non‑thermal energy to create selective cardiac lesions, reducing thermal injury and procedural risk. The system includes the AccuBlator generator, dedicated PFA catheters, and an AI‑enhanced 3D electroanatomic mapping solution that provides precise catheter localization, high‑density signal acquisition, and supports zero‑radiation workflows for electrophysiology physicians.
Funding
$6.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cardiac arrhythmia patients, especially those with atrial fibrillation, rely on catheter ablation that uses radiofrequency or cryoenergy, which can cause thermal injury, embolic events, and inconsistent long‑term outcomes. The lack of non‑thermal, tissue‑selective ablation and integrated high‑precision mapping limits safety and procedural efficiency.
Solution
AccuPulse develops a pulsed electric field ablation (PFA) platform that delivers high‑voltage, non‑thermal electric fields to induce irreversible electroporation of cardiac tissue, achieving selective cell death while sparing surrounding structures. The system includes the AccuBlator generator and dedicated PFA catheters, enabling faster lesion creation with reduced risk of thermal damage. Complementing the ablation hardware, AccuPulse is building an AI‑enhanced 3D electroanatomic mapping system that provides precise catheter localization, high‑density intracardiac electrogram acquisition, and advanced noise control. Integrated with the PFA platform, the mapping solution streamlines workflow, improves lesion accuracy, and supports zero‑radiation procedures. Together, these technologies aim to deliver safer, more effective treatment for atrial fibrillation and other cardiac arrhythmias.
Target Audience
Primary customers are electrophysiology physicians and cardiac ablation centers seeking safer, more efficient solutions for atrial fibrillation and other arrhythmias, as well as hospitals and EP labs adopting advanced mapping and ablation technologies.
Features
- High‑voltage pulsed electric field generator (AccuBlator) that creates non‑thermal irreversible electroporation lesions
- Dedicated PFA catheters designed for efficient energy delivery and tissue selectivity
- AI‑driven 3D electroanatomic mapping system with smart magnetic and electrical localization integration
- High‑density intracardiac electrogram channels with advanced noise suppression for accurate signal mapping
- Open architecture supporting a wide range of diagnostic and therapeutic catheters, including high‑density mapping probes
- Compatibility with zero‑radiation workflow, reducing reliance on fluoroscopy during procedures